LEVOFLOXACIN – OFLOXACIN (OPHTHALMOLOGY - BACTERIAL EXTERNAL OCULAR INFECTIONS)

LEVOFLOXACIN – OFLOXACIN  (OPHTHALMOLOGY - BACTERIAL EXTERNAL OCULAR INFECTIONS)
Product Description

Ofloxacin is a second-generation fluoroquinolone. Levofloxacin is a third-generation fluoroquinolone and is the pure L-enantiomer of ofloxacin. 
Fluoroquinolones are broad spectrum bactericidal agents with activity against many of the important corneal pathogens including staphylococci, Neisseria gonorrhoea, Haemophilus influenzae, Enterobacteriaceae, and Pseudomonas aeruginosa. Levofloxacin is the antibiotic of choice for many therapeutic indications according to ESCRS (European Society of Cataract & Refractive Surgeons).

Presentations: 
Levofloxacin: 5mg/ml - bottle 5ml multidose eye drops preserved or preservative free. 
Ofloxacin: 10ml bottle and 20x0.5ml single dose

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
Specifications
  • Selling Points
    Product Performance
  • Supplied from
    Italy

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

More Products from NTC S.r.l. (29)

NTC S.r.l. resources (1)

  • Brochure Therapeutical areas - brochure

    Advanced scientific research and technology drive our efforts to innovate care practices.
    Our range of products builds from our historical vocation for innovation aimed at improving the experience of patients and healthcare practices.
    An innovation aimed at discovering specific therapeutic gestures: simple and intuitive,  sustainable, and technically advanced for empowering the patient.
    Our research aims to put pioneering new products within the reach of everyone and to optimize the
    performance of our products by analyzing the daily needs and habits of people undergoing treatment.
    We research, develop and produce innovative drugs, medical devices and food supplements.
    We market our products worldwide through licensing, distribution, marketing, and commercial deals with partner companies.
    Our core therapeutic areas are: Ophthalmology, Gastro-Metabolism, Pediatrics and Gynacology.